Q1 2026 earnings call: ficera trial updates, FDA-guided dosing study, cash runway and 2027 catalysts—read key takeaways now.
May 14, 2026 – Vancouver, BC, Canada – Tiernan Gold Corp. (TSX-V : TNGD) (“Tiernan” or the “Company”) announces the initiation of a comprehensive suite of technical and environmental studies in ...
Tiernan Gold Corp. (TSXV: TNGD) ("Tiernan" or the "Company") announces the initiation of a comprehensive suite of technical and environmental ...
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for high-impact indications, today announced the official commencement of ...
April 20, 2026 - PRESSADVANTAGE - Infintech Designs, a digital marketing and web design agency, has published a ...
KT-621 parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late 2027, respectively WATERTOWN, Mass., (GLOBE NEWSWIRE) -- Kymera ...
The bigger opportunity in AI isn't the tools. It's how the companies building them operate. Five crazy shifts in ...
A new multi-institution study found physicians collaborating with AI chatbots performed as well as the AI alone in nuanced clinical management decisions, outperforming doctors without AI support. The ...
For Kathy Tran, choosing to major in computer science (CS) at Georgia Tech was never about narrowing her interests. Drawn to both computing and film, she sought flexibility to explore technical ...
Hosted on MSN
UNO study finds students shifting to critical AI use
A University of Nebraska Omaha study found students are moving from passive to more critical and active uses of generative AI in coursework. Using a custom chatbot in a business plan project, ...
Initial Study to Evaluate Entolimod for Gastrointestinal Tissue Preservation in Partial-Body Acute Radiation Syndrome - an Indication for Which No Currently Approved ...
New data from IM1240 (capped-CD3 × 5T4 × NKG2A) tri-specific antibody demonstrated potent anti-tumor activity across all treatment-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results